Lung injury induced by TiO2 nanoparticles depends on their structural features: Size, shape, crystal phases, and surface coating

International Journal of Molecular Sciences

Volumn 15, Issue 12, 2014, Pages 22258-22278

  Wang, Jiangxue ^a   Fan, Yubo ^a  

^a BEIHANG UNIVERSITY   (China)

Author keywords

Lung injury; Nanotoxicology; Physicochemical property; Pulmonary inflammation; TiO2 nanoparticles

Indexed keywords

ALUMINUM OXIDE; HEME OXYGENASE 1; NANOCOATING; REACTIVE OXYGEN METABOLITE; SILICON DIOXIDE; TITANIUM DIOXIDE NANOPARTICLE; TRANSCRIPTION FACTOR NRF1; TUMOR NECROSIS FACTOR ALPHA; BIOMATERIAL; NANOPARTICLE; TITANIUM; TITANIUM DIOXIDE;

BIOLOGICAL ACTIVITY; CRYSTAL STRUCTURE; CYTOTOXICITY; DNA DAMAGE; DNA STRAND BREAKAGE; GENOTOXICITY; HUMAN; LUNG ALVEOLUS MACROPHAGE; LUNG INJURY; NANOTOXICOLOGY; NONHUMAN; OXIDATIVE STRESS; PARTICLE SIZE; PHYSICAL CHEMISTRY; PNEUMONIA; REVIEW; ANIMAL; CHEMICALLY INDUCED; CHEMISTRY; CRYSTALLIZATION;

ANIMALS; COATED MATERIALS, BIOCOMPATIBLE; CRYSTALLIZATION; HUMANS; LUNG INJURY; NANOPARTICLES; PARTICLE SIZE; TITANIUM;

EID: 84919346343     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms151222258     Document Type: Review

References (78)

1. Chusuei, C.C.; Wu, C.H.; Mallavarapu, S.; Hou, F.Y.; Hsu, C.M.; Winiarz, J.G.; Aronstam, R.S.; Huang, Y.W. Cytotoxicity in the age of nano: The role of fourth period transition metal oxide nanoparticle physicochemical properties. Chem. Biol. Interact.2013, 206, 319–326.
2. Nel, A.; Xia, T.; Madler, L.; Li, N. Toxic potential of materials at the nanolevel. Science2006, 311, 622–627.
3. Donaldson, K.; Stone, V.; Tran, C.L.; Kreyling, W.; Borm, P.J.A. Nanotoxicology: A new frontier in particle toxicology relevant to both the workplace and general environment and to consumer safety. Occup. Environ. Med.2004, 61, 727–728.
4. Colvin, V.L. The potential environmental impact of engineered nanomaterials. Nat. Nanotechnol.2003, 21, 1166–1170.
5. Oberdorster, G.; Oberdorster, E.; Oberdorster, J. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect.2005, 113, 823–839.
6. Diebold, U. The surface science of titanium dioxide. Surf. Sci. Rep.2003, 48, 53–229.
7. Warheit, D.B.; Hoke, R.A.; Finlay, C.; Donner, E.M.; Reed, K.L.; Sayes, C.M. Development of a base set of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management. Toxicol. Lett.2007, 171, 99–110.
8. Wang, J.; Zhou, G.; Chen, C.; Yu, H.; Wang, T.; Ma, Y.; Jia, G.; Gao, Y.; Li, B.; Sun, J. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol. Lett.2007, 168, 176–185.
9. Wang, J.X.; Chen, C.Y.; Yu, H.W.; Sun, J.; Li, B.; Li, Y.F.; Gao, Y.X.; He, W.; Huang, Y.Y.; Chai, Z.F. et al. Distribution of TiO2 particles in the olfactory bulb of mice after nasal inhalation using microbeam SRXRF mapping techniques. J. Radioanal. Nucl. Chem.2007, 272, 527–531.
10. Ferin, J.; Oberdörster, G.; Penney, D.P. Pulmonary retention of ultrafine and fine particles in rats. Am. J. Respir. Cell Mol. Biol.1992, 6, 535–542.
11. Oesch, F.; Landsiedel, R. Genotoxicity investigations on nanomaterials. Arch. Toxicol. 2012, 86, 985–994.
12. The National Institute for Occupational Safety and Health (NIOSH). NIOSH Current Intelligence Bulletin 63: Occupational Exposure to Titanium Dioxide; NIOSH publication: Atlanta, GA, USA, 2011.
13. Boffetta, P.; Soutar, A.; Cherrie, J.W.; Granath, F.; Andersen, A.; Anttila, A.; Blettner, M.; Gaborieau, V.; Klug, S.J.; Langard, S. et al. Mortality among workers employed in the titanium dioxide production industry in Europe. Cancer Causes Control. 2004, 15, 697–706.
14. Hext, P.M.; Tomenson, J.A.; Thompson, P. Titanium dioxide: Inhalation toxicology and epidemiology. Ann. Occup. Hyg.2005, 49, 461–472.
15. Pope, C.A., Epidemiology of fine particulate air pollution and human health: Biologic mechanisms and whos at risk? Environ. Health Perspect.2000, 108, 713–723.
16. Baan, R.; Straif, K.; Grosse, Y.; Secretan, B.A.; el Ghissassi, F.; Cogliano, V. Carcinogenicity of carbon black, titanium dioxide, and talc. Lancet Oncol. 2006, 7, 295–296.
17. Bermudez, E.; Mangum, J.B.; Asgharian, B.; Wong, B.A.; Reverdy, E.E.; Janszen, D.B.; Hext, P.M.; Warheit, D.B.; Everitt, J.I. Long-term pulmonary responses of three laboratory rodent species to subchronic inhalation of pigmentary titanium dioxide particles. Toxicol. Sci.2002, 70, 86–97.
18. Bermudez, E.; Mangum, J.B.; Wong, B.A.; Asgharian, B.; Hext, P.M.; Warheit, D.B.; Everitt, J.I. Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicol. Sci.2004, 77, 347–357.
19. Henderson, R.F.; Driscoll, K.E.; Harkema, J.R.; Lindenschmidt, R.C.; Chang, I.Y.; Maples, K.R.; Barr, E.B. A comparison of the inflammatory response of the lung to inhaled versus instilled particles in F344 rats. Fundam. Appl. Toxicol.1995, 24, 183–197.
20. Oberdorster, G.; Ferin, J.; Gelein, R.; Soderholm, S.C.; Finkelstein, J. Role of the alveolar macrophage in lung injury: Studies with ultrafine particles. Environ. Health Perspect.1992, 97, 193–199.
21. Oberdorster, G.; Finkelstein, J.N.; Johnston, C.; Gelein, R.; Cox, C.; Baggs, R.; Elder, A.C. Acute pulmonary effects of ultrafine particles in rats and mice. Health Effects Inst. Res. Rep.2000, 96, 5–74.
22. Osier, M.; Oberdorster, G. Intratracheal inhalation vs intratracheal instillation: Differences in particle effects. Fundam. Appl. Toxicol.1997, 40, 220–227.
23. Osier, M.; Baggs, R.B.; Oberdorster, G. Intratracheal instillation versus intratracheal inhalation: Influence of cytokines on inflammatory response. Environ. Health Perspect.1997, 105, 1265–1271.
24. Warheit, D.B.; Hansen, J.F.; Yuen, I.S.; Kelly, D.P.; Snajdr, S.I.; Hartsky, M.A. Inhalation of high concentrations of low toxicity dusts in rats results in impaired pulmonary clearance mechanisms and persistent inflammation. Toxicol. Appl. Pharmacol.1997, 145, 10–22.
25. Donaldson, K.; Li, X.Y.; MacNee, W. Ultrafine (nanometre) particle mediated lung injury. J. Aerosol Sci.1998, 29, 553–560.
26. Ma-Hock, L.; Burkhardt, S.; Strauss, V.; Gamer, A.O.; Wiench, K.; van Ravenzwaay, B.; Landsiedel, R. Development of a short-term inhalation test in the rat using nano-titanium dioxide as a model substance. Inhal. Toxicol.2009, 21, 102–118.
27. Husain, M.; Saber, A.T.; Guo, C.; Jacobsen, N.R.; Jensen, K.A.; Yauk, C.L.; Williams, A.; Vogel, U.; Wallin, H.; Halappanavar, S. Pulmonary instillation of low doses of titanium dioxide nanoparticles in mice leads to particle retention and gene expression changes in the absence of inflammation. Toxicol. Appl. Pharmacol.2013, 269, 250–262.
28. Shi, H.; Magaye, R.; Castranova, V.; Zhao, J. Titanium dioxide nanoparticles: A review of current toxicological data. Part. Fibre Toxicol.2013, 10, 15.
29. Verma, A.; Stellacci, F. Effect of surface properties on nanoparticle-cell interactions. Small2010, 6, 12–21.
30. Iavicoli, I.; Leso, V.; Fontana, L.; Bergamaschi, A. Toxicological effects of titanium dioxide nanoparticles: A review of in vitro mammalian studies. Eur. Rev. Med. Pharmacol. Sci.2011, 15, 481–508.
31. Hsieh, T.H.; Yu, C.P.; Oberdorster, G. Modeling of deposition and clearance of inhaled Ni compounds in the human lung. Regul. Toxicol. Pharmacol.1999, 30, 18–28.
32. ICRP. ICRP Publication 66: Human Respiratory Tract Model for Radiological Protection, 66th ed.; Elsevier Health Sciences: Oxford, UK, 1994.
33. Renwick, L.C.; Donaldson, K.; Clouter, A. Impairment of alveolar macrophage phagocytosis by ultrafine particles. Toxicol. Appl. Pharm.2001, 172, 119–127.
34. Oberdorster, G.; Ferin, J.; Lehnert, B.E. Correlation between particle size, in vivo particle persistence, and lung injury. Environ. Health Perspect.1994, 102, 173–179.
35. Gibbs-Flournoy, E.A.; Bromberg, P.A.; Hofer, T.P.; Samet, J.M.; Zucker, R.M. Darkfield-confocal microscopy detection of nanoscale particle internalization by human lung cells. Part. Fibre Toxicol.2011, 8, 2.
36. Chen, H.W.; Su, S.F.; Chien, C.T.; Lin, W.H.; Yu, S.L.; Chou, C.C.; Chen, J.J.; Yang, P.C. Titanium dioxide nanoparticles induce emphysema-like lung injury in mice. FASEB J. 2006, 20, 2393–2395.
37. Hubbard, A.K.; Timblin, C.R.; Shukla, A.; Rincón, M.; Mossman, B.T. Activation of NF-κB-dependent gene expression by silica in lungs of luciferase reporter mice. Am. J. Physiol. Lung Cell. Mol. Physiol.2002, 282, L968–L975.
38. Gurr, J.-R.; Wang, A.S.S.; Chen, C.-H.; Jan, K.-Y. Ultrafine titanium dioxide particles in the absence of photoactivation can induce oxidative damage to human bronchial epithelial cells. Toxicology2005, 213, 66–73.
39. Porter, D.W.; Wu, N.; Hubbs, A.F.; Mercer, R.R.; Funk, K.; Meng, F.; Li, J.; Wolfarth, M.G.; Battelli, L.; Friend, S. et al. Differential mouse pulmonary dose and time course responses to titanium dioxide nanospheres and nanobelts. Toxicol. Sci.2013, 131, 179–193.
40. Nemmar, A.; Melghit, K.; Ali, B.H. The acute proinflammatory and prothrombotic effects of pulmonary exposure to rutile TiO2 nanorods in rats. Exp. Biol. Med.2008, 233, 610–619.
41. Warheit, D.B.; Webb, T.R.; Sayes, C.M.; Colvin, V.L.; Reed, K.L. Pulmonary instillation studies with nanoscale TiO2 rods and dots in rats: Toxicity is not dependent upon particle size and surface area. Toxicol. Sci. 2006, 91, 227–236.
42. Silva, R.M.; Teesy, C.; Franzi, L.; Weir, A.; Westerhoff, P.; Evans, J.E.; Pinkerton, K.E. Biological response to nano-scale titanium dioxide (TiO2): Role of particle dose, shape, and retention. J. Toxicol. Environ. Health A2013, 76, 953–972.
43. Bonner, J.C.; Silva, R.M.; Taylor, A.J.; Brown, J.M.; Hilderbrand, S.C.; Castranova, V.; Porter, D.; Elder, A.; Oberdorster, G.; Harkema, J.R. et al. Interlaboratory evaluation of rodent pulmonary responses to engineered nanomaterials: The NIEHS Nano GO Consortium. Environ. Health Perspect.2013, 121, 676–682.
44. Warheit, D.B.; Brock, W.J.; Lee, K.P.; Webb, T.R.; Reed, K.L. Comparative pulmonary toxicity inhalation and instillation studies with different TiO2 particle formulations: Impact of Surface Treatments on Particle Toxicity. Toxicol. Sci. 2005, 88, 514–524.
45. Rossi, E.M.; Pylkkänen, L.; Koivisto, A.J.; Vippola, M.; Jensen, K.A.; Miettinen, M.; Sirola, K.; Nykäsenoja, H.; Karisola, P.; Stjernvall, T. et al. Airway exposure to silica-coated TiO2 nanoparticles induces pulmonary neutrophilia in mice. Toxicol. Sci.2010, 113, 422–433.
46. Oberdorster, G. Pulmonary effects of inhaled ultrafine particles. Int. Arch. Occup. Environ. Health2001, 74, 1–8.
47. Smulders, S.; Luyts, K.; Brabants, G.; Landuyt, K.V.; Kirschhock, C.; Smolders, E.; Golanski, L.; Vanoirbeek, J.; Hoet, P.H. Toxicity of nanoparticles embedded in paints compared with pristine nanoparticles in mice. Toxicol. Sci.2014, 141, 132–140.
48. Warheit, D.B.; Webb, T.R.; Reed, K.L.; Frerichs, S.; Sayes, C.M. Pulmonary toxicity study in rats with three forms of ultrafine-TiO2 particles: Differential responses related to surface properties. Toxicology2007, 230, 90–104.
49. Rehn, B.; Seiler, F.; Rehn, S.; Bruch, J.; Maier, M. Investigations on the inflammatory and genotoxic lung effects of two types of titanium dioxide: Untreated and surface treated. Toxicol. Appl. Pharmacol.2003, 189, 84–95.
50. Hohr, D.; Steinfartz, Y.; Schins, R.P.; Knaapen, A.M.; Martra, G.; Fubini, B.; Borm, P.J. The surface area rather than the surface coating determines the acute inflammatory response after instillation of fine and ultrafine TiO2 in the rat. Int. J. Hyg. Environ. Health2002, 205, 239–244.
51. Jugan, M.L.; Barillet, S.; Simon-Deckers, A.; Sauvaigo, S.; Douki, T.; Herlin, N.; Carrière, M. Cytotoxic and genotoxic impact of TiO2 nanoparticles on A549 cells. J. Biomed. Nanotechnol.2011, 7, 22–23.
52. Jugan, M.-L.; Barillet, S.; Simon-Deckers, A.; Herlin-Boime, N.; Sauvaigo, S.; Douki, T.; Carriere, M. Titanium dioxide nanoparticles exhibit genotoxicity and impair DNA repair activity in A549 cells. Nanotoxicology2012, 6, 501–513.
53. Magrez, A.; Horvath, L.; Smajda, R.; Salicio, V.; Pasquier, N.; Forro, L.; Schwaller, B. Cellular toxicity of TiO2-based nanofilaments. ACS Nano2009, 3, 2274–2280.
54. Hamilton, R.F.; Wu, N.; Porter, D.; Buford, M.; Wolfarth, M.; Holian, A. Particle length-dependent titanium dioxide nanomaterials toxicity and bioactivity. Part. Fibre Toxicol.2009, 6, 35.
55. Chen, J.; Zhou, H.; Santulli, A.C.; Wong, S.S. Evaluating cytotoxicity and cellular uptake from the presence of variously processed TiO2 nanostructured morphologies. Chem. Res. Toxicol.2010, 23, 871–879.
56. Xia, T.; Hamilton, R.F.; Bonner, J.C.; Crandall, E.D.; Elder, A.; Fazlollahi, F.; Girtsman, T.A.; Kim, K.; Mitra, S.; Ntim, S.A. et al. Interlaboratory evaluation of in vitro cytotoxicity and inflammatory responses to engineered nanomaterials: The NIEHS Nano GO Consortium. Environ. Health Perspect.2013, 121, 683–690.
57. Simon-Deckers, A.; Gouget, B.; Mayne-L’Hermite, M.; Herlin-Boime, N.; Reynaud, C.; Carrière, M. In vitro investigation of oxide nanoparticle and carbon nanotube toxicity and intracellular accumulation in A549 human pneumocytes. Toxicology2008, 253, 137–146.
58. Sayes, C.M.; Wahi, R.; Kurian, P.A.; Liu, Y.P.; West, J.L.; Ausman, K.D.; Warheit, D.B.; Colvin, V.L. Correlating nanoscale titania structure with toxicity: A cytotoxicity and inflammatory response study with human dermal fibroblasts and human lung epithelial cells. Toxicol. Sci.2006, 92, 174–185.
59. Falck, G.; Lindberg, H.; Suhonen, S.; Vippola, M.; Vanhala, E.; Catalán, J.; Savolainen, K.; Norppa, H. Genotoxic effects of nanosized and fine TiO2. Hum. Exp. Toxicol.2009, 28, 339–352.
60. Hamzeh, M.; Sunahara, G.I. In vitro cytotoxicity and genotoxicity studies of titanium dioxide (TiO2) nanoparticles in Chinese hamster lung fibroblast cells. Toxicol. Vitro 2013, 27, 864–873.
61. Braydich-Stolle, L.; Schaeublin, N.; Murdock, R.; Jiang, J.; Biswas, P.; Schlager, J.; Hussain, S. Crystal structure mediates mode of cell death in TiO2 nanotoxicity. J. Nanopart. Res.2009, 11, 1361–1374.
62. Thevenot, P.; Cho, J.; Wavhal, D.; Timmons, R.B.; Tang, L. Surface chemistry influences cancer killing effect of TiO2 nanoparticles. Nanomed: Nanotechnol. Biol. Med.2008, 4, 226–236.
63. Sweeney, S.; Berhanu, D.; Ruenraroengsak, P.; Thorley, A.J.; Valsami-Jones, E.; Tetley, T.D. Nano-titanium dioxide bioreactivity with human alveolar type-I-like epithelial cells: Investigating crystalline phase as a critical determinant. Nanotoxicology2014, 19, 1–11.
64. Noël, A.; Maghni, K.; Cloutier, Y.; Dion, C.; Wilkinson, K.J.; Hallé, S.; Tardif, R.; Truchon, G. Effects of inhaled nano-TiO2 aerosols showing two distinct agglomeration states on rat lungs. Toxicol. Lett.2012, 214, 109–119.
65. Noël, A.; Cloutier, Y.; Wilkinson, K.J.; Dion, C.; Hallé, S.; Maghni, K.; Tardif, R.; Truchon, G. Generating nano-aerosols from TiO2 (5 nm) nanoparticles showing different agglomeration states. Application to toxicological studies. J. Occup. Environ. Hyg.2013, 10, 86–96.
66. Noël, A.; Charbonneau, M.; Cloutier, Y.; Tardif, R.; Truchon, G. Rat pulmonary responses to inhaled nano-TiO2: Effect of primary particle size and agglomeration state. Part. Fibre Toxicol.2013, 10, 48.
67. Ferin, J.; Oberdorster, G. Biological effects and toxicity assessment of titanium dioxides: Anatase and rutile. Am. Ind. Hyg. Assoc. J.1985, 46, 69–72.
68. Jiang, J.; Oberdorster, G.; Elder, A.; Gelein, R.; Mercer, P.; Biswas, P. Does nanoparticle activity depend upon size and crystal phase? Nanotoxicology2008, 2, 33–42.
69. Pott, F.; Althoff, G.H.; Roller, M.; Hoehr, D.; Friemann, J.L. High acute toxicity of hydrophobic ultrafine titanium dioxide in an intratracheal study with several dusts in rats [A]. In Relationships between Respiratory Disease and Exposure to Air Pollution [C]; ILSI Press: Washington, DC, USA, 1998; pp. 270–277.
70. Wang, J.; Fan, Y.; Gao, Y.; Hu, Q.; Wang, T. TiO2 nanoparticles translocation and potential toxicological effect in rats after intraarticular injection. Biomaterials2009, 30, 4590–4600.
71. Li, B.; Ze, Y.; Sun, Q.; Zhang, T.; Sang, X.; Cui, Y.; Wang, X.; Gui, S.; Tan, D.; Zhu, M. et al. Molecular mechanisms of nanosized titanium dioxide-induced pulmonary injury in mice. PLoS One2013, 8, e55563.
72. Bhattacharya, K.; Davoren, M.; Boertz, J.; Schins, R.P.; Hoffmann, E.; Dopp, E. Titanium dioxide nanoparticles induce oxidative stress and DNA-adduct formation but not DNA-breakage in human lung cells. Part. Fibre Toxicol.2009, 6, 17.
73. Tang, Y.; Wang, F.; Jin, C.; Liang, H.; Zhong, X.; Yang, Y. Mitochondrial injury induced by nanosized titanium dioxide in A549 cells and rats. Environ. Toxicol. Pharmacol.2013, 36, 66–72.
74. Singh, S.; Shi, T.; Duffin, R.; Albrecht, C.; Vanberlo, D.; Hohr, D.; Fubini, B.; Martra, G.; Fenoglio, I.; Borm, P. Endocytosis, oxidative stress and IL-8 expression in human lung epithelial cells upon treatment with fine and ultrafine TiO2: Role of the specific surface area and of surface methylation of the particles. Toxicol. Appl. Pharmacol.2007, 222, 141–151.
75. Sun, Q.; Tan, D.; Zhou, Q.; Liu, X.; Cheng, Z.; Liu, G.; Zhu, M.; Sang, X.; Gui, S.; Cheng, J. et al. Oxidative damage of lung and its protective mechanism in mice caused by long-term exposure to titanium dioxide nanoparticles. J. Biomed. Mater. Res. A2012, 100A, 2554–2562.
76. Yazdi, A.S.; Guarda, G.; Riteau, N.; Drexler, S.K.; Tardivel, A.; Couillin, I.; Tschopp, J. Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β. Proc. Natl. Acad. Sci. USA2010, 107, 19449–19454.
77. Xia, T.; Kovochich, M.; Brant, J.; Hotze, M.; Sempf, J.; Oberley, T.; Sioutas, C.; Yeh, J.I.; Wiesner, M.R.; Nel, A.E. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett. 2006, 6, 1794–1807.
78. Scherbart, A.M.; Langer, J.; Bushmelev, A.; van Berlo, D.; Haberzettl, P.; van Schooten, F.J.; Schmidt, A.M.; Rose, C.R.; Schins, R.P.; Albrecht, C. Contrasting macrophage activation by fine and ultrafine titanium dioxide particles is associated with different uptake mechanisms. Part. Fibre Toxicol.2011, 8, 31.